Atlas Trials

6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124)

Clinical trial NCT01098110 · COMPLETED

Trial details

NCT number
NCT01098110
Sponsor
Organon and Co
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2010-05-25
Primary completion
2014-04-14
Enrollment
532

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.